Last reviewed · How we verify
NCT03609255
Health Effects of Reducing Sedentary Behavior
NA trial testing Reducing sedentary behavior in General Population in 21 participants. Completed in 8 October 2018.
8 October 2018
Quick facts
| Lead sponsor | Texas Tech University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 21 |
| Start date | 13 August 2018 |
| Primary completion | 8 October 2018 |
| Estimated completion | 8 October 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Reducing sedentary behavior
- Reducing stress
- Control
Conditions studied
- General Population — all drugs for General Population →
Sponsor
Texas Tech University
Who can join
Adults 18 to 65, any sex, with General Population. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A recent review indicated that sedentary behavior has been associated with increased morbidity and mortality but the intervention studies frequently focus only on changing sedentary behavior (reducing sedentary time) without measuring health-associated outcomes. Elevated cortisol (related to stress) has been linked with health risks. Improved physical fitness has been linked with improved cortisol responses to psychosocial stressors. In addition, increased physical activity induced favorable effects upon low density lipoprotein, high density lipoprotein, and total cholesterol. Previous study also indicated that increasing daily steps have positive effect on blood glucose in people with impaired glucose tolerance. Ultimately, the investigators think that sedentary intervention and stress management may have benefits on these health indicators. As such the investigators will examine whether sedentary intervention or stress management can have positive effect on human health by measuring salivary cortisol, blood lipid profile, fasting blood glucose, blood pressure, resting energy expenditure, and body composition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03609255
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for General Population
Currently open trials in the same condition.
- NCT06166810 — Capture of Healthy Gut Bacteria Associated to High Fiber Diet · recruiting
- NCT05758961 — Le French Gut: Characterization of Gut Microbiota Profiles in France · recruiting
- NCT05328856 — Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being · NA · recruiting
Other Texas Tech University trials
Trials by the same sponsor.
- NCT06755827 — Pilot Testing a Novel Approach to Pediatric Obesity Treatment · Phase 1, PHASE2 · recruiting
- NCT07239609 — ACT for Individuals With MNCD and Their Care Partners · Phase 1 · not yet recruiting
- NCT06919536 — Controlled Feeding With 24 Hour Recall · completed
- NCT06055322 — Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD · NA · recruiting
- NCT06865196 — Investigating a Brief Virtual Seminar Series for Parents of Teens Ages 13-17 · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03609255 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas Tech University
- Last refreshed: 24 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03609255.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing